Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records
Acute Exacerbations of COPD (AECOPD) identified from electronic healthcare records (EHR) are important for research, public health and to inform healthcare utilisation and service provision. However, there is no standardised method of identifying AECOPD in UK EHR. We aimed to validate the recording...
Saved in:
| Published in | PloS one Vol. 11; no. 3; p. e0151357 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
09.03.2016
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0151357 |
Cover
| Summary: | Acute Exacerbations of COPD (AECOPD) identified from electronic healthcare records (EHR) are important for research, public health and to inform healthcare utilisation and service provision. However, there is no standardised method of identifying AECOPD in UK EHR. We aimed to validate the recording of AECOPD in UK EHR.
We randomly selected 1385 patients with COPD from the Clinical Practice Research Datalink. We selected dates of possible AECOPD based on 15 different algorithms between January 2004 and August 2013. Questionnaires were sent to GPs asking for confirmation of their patients' AECOPD on the dates identified and for any additional relevant information. Responses were reviewed independently by two respiratory physicians. Positive predictive value (PPV) and sensitivity were calculated.
The response rate was 71.3%. AECOPD diagnostic codes, lower respiratory tract infection (LRTI) codes, and prescriptions of antibiotics and oral corticosteroids (OCS) together for 5-14 days had a high PPV (>75%) for identifying AECOPD. Symptom-based algorithms and prescription of antibiotics or OCS alone had lower PPVs (60-75%). A combined strategy of antibiotic and OCS prescriptions for 5-14 days, or LRTI or AECOPD code resulted in a PPV of 85.5% (95% CI, 82.7-88.3%) and a sensitivity of 62.9% (55.4-70.4%).
Using a combination of diagnostic and therapy codes, the validity of AECOPD identified from EHR can be high. These strategies are useful for understanding health-care utilisation for AECOPD, informing service provision and for researchers. These results highlight the need for common coding strategies to be adopted in primary care to allow easy and accurate identification of events. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: We have the following interests. This study was partly supported by a GlaxoSmithKline and Medical Research Council (MRC) industry partnership award. Hana Müllerová and Kourtney Davis are employed by GSK and hold stock and share options of GlaxoSmithKline Plc. JKQ reports grants from MRC, grants from GSK, during the conduct of the study; grants from MRC, grants from BLF, personal fees from AZ, personal fees from GSK, grants from Wellcome Trust, outside the submitted work. JRH reports personal fees from Pharmaceutical companies interested in COPD including AZ, Chiesi, GSK, Novartis, Pfizer, Takeda, outside the submitted work. Imperial College of Science, Technology and Medicine. LS reports grants from Wellcome Trust, during the conduct of the study; grants from Wellcome Trust, grants from MRC, grants from NIHR, personal fees from GSK, outside the submitted work. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. Conceived and designed the experiments: KJR HM LS KD SLT JKQ. Performed the experiments: KJR JRH JKQ. Analyzed the data: KJR HM JKQ. Contributed reagents/materials/analysis tools: KJR HM JRH LS KD SLT JKQ. Wrote the paper: KJR HM JRH LS KD SLT JKQ. |
| ISSN: | 1932-6203 1932-6203 |
| DOI: | 10.1371/journal.pone.0151357 |